Clinical Trials in Baltimore

Showing 3141-3160 of 20,142 trials

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

NCT03434392

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

Chronic PancreatitisChronic Pain

Anna Evans Phillips500 participantsStarted Oct 2017

Baltimore, Maryland, United States • Pittsburgh, Pennsylvania, United States

Enrolling By Invitation< 1 mile

The Johns Hopkins Heartburn Center Registry

NCT03853772

A multi-center, multi-year registry of patients with gastroesophageal reflux disease (GERD) undergoing diagnostic evaluation and/or treatment of GERD and associated diseases and complications.

Gastroesophageal Reflux DiseaseBarrett EsophagusLaryngopharyngeal Reflux+1 more

Johns Hopkins University2,000 participantsStarted Apr 2019

Orange, California, United States • Baltimore, Maryland, United States • Rochester, Minnesota, United States +6 more locations

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

The Johns Hopkins Heartburn Center Registry

Find Trials by Condition in Baltimore

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Blue Light Cystoscopy With Cysview® Registry

NATIENS: Optimal Management and Mechanisms of SJS/TEN

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Multisite Virtual Reality Intervention for Speech Anxiety

SyncAV Post-Market Trial

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID